Baumer

Baumer Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Baumer (BALM4.SA) as of Nov 21, 2026 is 96.88 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 261.15 % — a change of -62.90% (lower).

Cash Conversion

96.88 %

YoY

-62.90%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Baumer is 2024 96.88 % . Cash Conversion Rate (OCF/Net Income) of Baumer was 2023 261.15 % . It decreases by -62.90% lower compared to the previous year.

The Baumer Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2017
819.85 BRL
Jan 1, 2018
-104.25 BRL
Jan 1, 2019
232.34 BRL
Jan 1, 2020
154.56 BRL
Jan 1, 2021
110.43 BRL
Jan 1, 2022
54.63 BRL
Jan 1, 2023
261.15 BRL
Jan 1, 2024
96.88 BRL
The Baumer Cash Conversion history
YEARCash ConversionYoY
96.88 %-62.90%
261.15 %+378.04%
54.63 %-50.53%
110.43 %-28.55%
154.56 %-33.48%
232.34 %-322.87%
-104.25 %-112.72%
819.85 %+3,128.03%
25.40 %-23.65%
33.26 %-24.03%
43.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Cash Conversion Rate (OCF/Net Income) of Baumer is 96.88 % in 2024.

Cash Conversion Rate (OCF/Net Income) of Baumer changed from 261.15 % to 96.88 %, representing a -62.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Baumer since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Baumer with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Baumer

All Key Metrics — Baumer